Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder CancerFemale Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Non-Muscle Invasive Bladder Neoplasms, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, carcinoma, epithelial neoplasm, neoplasm, urinary bladder disorder, urinary bladder neoplasm, urinary system disorderActive, not recruitingPhase 12026-08-06NCT05483868

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Aura Biosciences6

19 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Arkansas UrologyLittle RockUnited States27
Austin HealthHeidelbergAustralia70
Baylor College of MedicineHoustonUnited States306
Carolina Urologic Research CenterMyrtle BeachUnited States1
Colorado Clinical ResearchLakewoodUnited States20
Hollywood Private HospitalNedlandsAustralia11
Montefiore Medical CenterThe BronxUnited States79
Penninsula Private HospitalLangwarrinAustralia1
Saint John's Cancer InstituteSanta MonicaUnited States17
The Royal Melbourne HospitalParkvilleAustralia26
The University of Texas San AntonioSan AntonioUnited States1
The Urology PlaceSan AntonioUnited States11
Tower UrologyLos AngelesUnited States9
UPMC Hillman Cancer CenterPittsburghUnited States330
Urology Associates, P.C.NashvilleUnited States12
Urology Clinics of North TexasDallasUnited States1
Urology San Antonio/USA Clinical TrialsSan AntonioUnited States1
Warringal Private HospitalHeidelbergAustralia1
Westmead Private HospitalWestmeadAustralia3